Clinical Trial Update: A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial updating results comparing insulin peglispro with insulin glargine as basal insulin in type 2 diabetes mellitus; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin Peglispro (insulin peglispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-03-15